Matches in SemOpenAlex for { <https://semopenalex.org/work/W1636240044> ?p ?o ?g. }
- W1636240044 endingPage "470" @default.
- W1636240044 startingPage "464" @default.
- W1636240044 abstract "Osteosarcoma (OS) is the most common malignant bone tumor affecting children and adolescents. Many patients are treated with a combination of chemotherapy, resection, and limb salvage protocols. Surgical reconstructions after tumor resection include structural allografts, non-cemented endoprostheses, and distraction osteogenesis (DO), which require direct bone formation. Although cisplatin (CDP) is extensively used for OS chemotherapy, the effects on bone regeneration are not well studied. The effects of CDP on direct bone formation in DO were compared using two dosing regimens and both C57BL/6 (B6) and tumor necrosis factor receptor 1 knockout (TNFR1KO) mice, as CDP toxicity is associated with elevated TNF levels. Detailed evaluation of the five-dose CDP regimen (2 mg/kg/day), demonstrated significant decreases in new bone formation in the DO gaps of CDP treated versus vehicle treated mice (p < 0.001). Further, no significant inhibitory effects from the five-dose CDP regimen were observed in TNFR1KO mice. The two-dose regimen significantly inhibited new bone formation in B6 mice. These results demonstrate that CDP has profound short term negative effects on the process of bone repair in DO. These data provide the mechanistic basis for modeling peri-operative chemotherapy doses and schedules and may provide new opportunities to identify molecules that spare normal cells from the inhibitory effects of CDP. © 2013 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:464–470, 2014." @default.
- W1636240044 created "2016-06-24" @default.
- W1636240044 creator A5020142407 @default.
- W1636240044 creator A5021089004 @default.
- W1636240044 creator A5022630042 @default.
- W1636240044 creator A5023669276 @default.
- W1636240044 creator A5027519120 @default.
- W1636240044 creator A5030656818 @default.
- W1636240044 creator A5038467519 @default.
- W1636240044 creator A5042045435 @default.
- W1636240044 creator A5042599014 @default.
- W1636240044 creator A5050464047 @default.
- W1636240044 creator A5052222380 @default.
- W1636240044 creator A5075871834 @default.
- W1636240044 creator A5088985774 @default.
- W1636240044 date "2013-11-20" @default.
- W1636240044 modified "2023-09-23" @default.
- W1636240044 title "Cisplatin inhibits bone healing during distraction osteogenesis" @default.
- W1636240044 cites W1570072228 @default.
- W1636240044 cites W1902222293 @default.
- W1636240044 cites W1966517386 @default.
- W1636240044 cites W1979392396 @default.
- W1636240044 cites W1985366141 @default.
- W1636240044 cites W2000964964 @default.
- W1636240044 cites W2006815805 @default.
- W1636240044 cites W2009729817 @default.
- W1636240044 cites W2010304287 @default.
- W1636240044 cites W2015641370 @default.
- W1636240044 cites W2018733786 @default.
- W1636240044 cites W2039421524 @default.
- W1636240044 cites W2047178442 @default.
- W1636240044 cites W2048511660 @default.
- W1636240044 cites W2057813792 @default.
- W1636240044 cites W2062309885 @default.
- W1636240044 cites W2067098190 @default.
- W1636240044 cites W2118833456 @default.
- W1636240044 cites W2142136189 @default.
- W1636240044 cites W2143226103 @default.
- W1636240044 cites W2161764708 @default.
- W1636240044 cites W2163036716 @default.
- W1636240044 cites W2163483579 @default.
- W1636240044 cites W2329218644 @default.
- W1636240044 cites W4241813594 @default.
- W1636240044 cites W4252024216 @default.
- W1636240044 doi "https://doi.org/10.1002/jor.22527" @default.
- W1636240044 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4080883" @default.
- W1636240044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24259375" @default.
- W1636240044 hasPublicationYear "2013" @default.
- W1636240044 type Work @default.
- W1636240044 sameAs 1636240044 @default.
- W1636240044 citedByCount "27" @default.
- W1636240044 countsByYear W16362400442015 @default.
- W1636240044 countsByYear W16362400442016 @default.
- W1636240044 countsByYear W16362400442017 @default.
- W1636240044 countsByYear W16362400442019 @default.
- W1636240044 countsByYear W16362400442020 @default.
- W1636240044 countsByYear W16362400442021 @default.
- W1636240044 countsByYear W16362400442022 @default.
- W1636240044 countsByYear W16362400442023 @default.
- W1636240044 crossrefType "journal-article" @default.
- W1636240044 hasAuthorship W1636240044A5020142407 @default.
- W1636240044 hasAuthorship W1636240044A5021089004 @default.
- W1636240044 hasAuthorship W1636240044A5022630042 @default.
- W1636240044 hasAuthorship W1636240044A5023669276 @default.
- W1636240044 hasAuthorship W1636240044A5027519120 @default.
- W1636240044 hasAuthorship W1636240044A5030656818 @default.
- W1636240044 hasAuthorship W1636240044A5038467519 @default.
- W1636240044 hasAuthorship W1636240044A5042045435 @default.
- W1636240044 hasAuthorship W1636240044A5042599014 @default.
- W1636240044 hasAuthorship W1636240044A5050464047 @default.
- W1636240044 hasAuthorship W1636240044A5052222380 @default.
- W1636240044 hasAuthorship W1636240044A5075871834 @default.
- W1636240044 hasAuthorship W1636240044A5088985774 @default.
- W1636240044 hasBestOaLocation W16362400441 @default.
- W1636240044 hasConcept C126322002 @default.
- W1636240044 hasConcept C141071460 @default.
- W1636240044 hasConcept C142724271 @default.
- W1636240044 hasConcept C169760540 @default.
- W1636240044 hasConcept C2776378700 @default.
- W1636240044 hasConcept C2776694085 @default.
- W1636240044 hasConcept C2776819169 @default.
- W1636240044 hasConcept C2777506904 @default.
- W1636240044 hasConcept C2777760704 @default.
- W1636240044 hasConcept C2778239845 @default.
- W1636240044 hasConcept C2781413609 @default.
- W1636240044 hasConcept C71924100 @default.
- W1636240044 hasConcept C8337478 @default.
- W1636240044 hasConcept C86803240 @default.
- W1636240044 hasConcept C98274493 @default.
- W1636240044 hasConceptScore W1636240044C126322002 @default.
- W1636240044 hasConceptScore W1636240044C141071460 @default.
- W1636240044 hasConceptScore W1636240044C142724271 @default.
- W1636240044 hasConceptScore W1636240044C169760540 @default.
- W1636240044 hasConceptScore W1636240044C2776378700 @default.
- W1636240044 hasConceptScore W1636240044C2776694085 @default.
- W1636240044 hasConceptScore W1636240044C2776819169 @default.
- W1636240044 hasConceptScore W1636240044C2777506904 @default.
- W1636240044 hasConceptScore W1636240044C2777760704 @default.